BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11875493)

  • 1. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition.
    Kreisel D; Krupnick AS; Gelman AE; Engels FH; Popma SH; Krasinskas AM; Balsara KR; Szeto WY; Turka LA; Rosengard BR
    Nat Med; 2002 Mar; 8(3):233-9. PubMed ID: 11875493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion.
    Kreisel D; Krupnick AS; Balsara KR; Riha M; Gelman AE; Popma SH; Szeto WY; Turka LA; Rosengard BR
    J Immunol; 2002 Dec; 169(11):6154-61. PubMed ID: 12444119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation.
    Boisgérault F; Liu Y; Anosova N; Ehrlich E; Dana MR; Benichou G
    J Immunol; 2001 Aug; 167(4):1891-9. PubMed ID: 11489968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection.
    Harper SJ; Ali JM; Wlodek E; Negus MC; Harper IG; Chhabra M; Qureshi MS; Mallik M; Bolton E; Bradley JA; Pettigrew GJ
    Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12788-93. PubMed ID: 26420874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 T cells are sufficient to mediate allorecognition and allograft rejection.
    Halamay KE; Kirkman RL; Sun L; Yamada A; Fragoso RC; Shimizu K; Mitchell RN; McKay DB
    Cell Immunol; 2002; 216(1-2):6-14. PubMed ID: 12381345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis.
    El-Sawy T; Miura M; Fairchild R
    Am J Pathol; 2004 Jul; 165(1):147-57. PubMed ID: 15215170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection.
    Kreisel D; Krasinskas AM; Krupnick AS; Gelman AE; Balsara KR; Popma SH; Riha M; Rosengard AM; Turka LA; Rosengard BR
    J Immunol; 2004 Sep; 173(5):3027-34. PubMed ID: 15322162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect allorecognition is involved in both acute and chronic allograft rejection.
    Fluck N; Witzke O; Morris PJ; Wood KJ
    Transplant Proc; 1999; 31(1-2):842-3. PubMed ID: 10083366
    [No Abstract]   [Full Text] [Related]  

  • 12. IL-5 and eosinophils mediate the rejection of fully histoincompatible vascularized cardiac allografts: regulatory role of alloreactive CD8(+) T lymphocytes and IFN-gamma.
    Braun MY; Desalle F; Le Moine A; Pretolani M; Matthys P; Kiss R; Goldman M
    Eur J Immunol; 2000 May; 30(5):1290-6. PubMed ID: 10820374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
    Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
    Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S; Flamand V; Goldman M; Braun MY
    Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CD8+ lymphocytes in chronic rejection of transplanted hearts.
    Fischbein MP; Yun J; Laks H; Irie Y; Fishbein MC; Bonavida B; Ardehali A
    J Thorac Cardiovasc Surg; 2002 Apr; 123(4):803-9. PubMed ID: 11986610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo differentiation of alloreactive CD8+ T cells after murine cardiac allograft transplantation.
    Gilot BJ; Hara M; Jones ND; van Maurik A; Hadjianastassiou V; Morris PJ; Wood KJ
    Transplant Proc; 1999; 31(1-2):130. PubMed ID: 10083042
    [No Abstract]   [Full Text] [Related]  

  • 17. Allograft dendritic cell p40 homodimers activate donor-reactive memory CD8+ T cells.
    Tsuda H; Su CA; Tanaka T; Ayasoufi K; Min B; Valujskikh A; Fairchild RL
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways of allorecognition: implications for transplantation tolerance.
    Game DS; Lechler RI
    Transpl Immunol; 2002 Aug; 10(2-3):101-8. PubMed ID: 12216939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.